Next Article in Journal
Serum Neutralization Profiles of Straw-Colored Fruit Bats (Eidolon helvum) in Makurdi (Nigeria), against Four Lineages of Lagos Bat Lyssavirus
Next Article in Special Issue
Decreased Fetal Movements: A Sign of Placental SARS-CoV-2 Infection with Perinatal Brain Injury
Previous Article in Journal
Systemic Inflammation and Complement Activation Parameters Predict Clinical Outcome of Severe SARS-CoV-2 Infections
Previous Article in Special Issue
The Current Evidence Regarding COVID-19 and Pregnancy: Where Are We Now and Where Should We Head to Next?
 
 
Communication
Peer-Review Record

Letter to the Editor: SFlt-1 and PlGF Levels in Pregnancies Complicated by SARS-CoV-2 Infection

Viruses 2021, 13(12), 2377; https://doi.org/10.3390/v13122377
by Valentina Giardini 1,*, Sara Ornaghi 1, Eleonora Acampora 1, Maria Viola Vasarri 1, Francesca Arienti 1, Carlo Gambacorti-Passerini 2, Marco Casati 3, Andrea Carrer 2 and Patrizia Vergani 1
Reviewer 1: Anonymous
Reviewer 2: Anonymous
Viruses 2021, 13(12), 2377; https://doi.org/10.3390/v13122377
Submission received: 16 November 2021 / Revised: 21 November 2021 / Accepted: 22 November 2021 / Published: 27 November 2021
(This article belongs to the Special Issue Emerging Virus Infections in Adverse Pregnancy Outcomes)

Round 1

Reviewer 1 Report

In this letter to the editor, the authors respond to an article by Espino-y-Sosa and colleagues (Espino-y-Sosa, S, et al. Novel Ratio Soluble Fms-like Tyrosine Kinase-1/Angiotensin-II (sFlt-1/ANG-II) in Pregnant Women Is Associated with Critical Illness in COVID-19. Viruses 2021, 13, 1906. https://doi.org/10.3390/v13101906), who recently reported that the Soluble Fms-like Tyrosine Kinase-1/Angiotensin-II (sFlt-1/ANG-II) ratio could be a good predictor of adverse outcomes, including pneumonia, intensive care unit (ICU) admission, intubation, viral sepsis, and death, among pregnant women with COVID-19. They present work from their own clinical practice and the work of others that confirm the paper’s findings. They also report differences in some of the findings from the Espino-y-Sosa et al. paper and offer possible explanations for the difference. The comparison is presented thoroughly with compelling importance for further research in a larger prospective study of the angiogenic profile during pregnancy in SARs-CoV-2 infected women that are symptomatic versus asymptomatic.

Author Response

We thank the Reviewer for his/her consideration and appreciation of our communication.

Reviewer 2 Report

I found this research letter on the correlation between preeclampsia (PE)
and COVID19 very intriguing. The data are clearly presented
and adequately support the conclusions. The fact that pregnant women with
asymptomatic COVID19 are at increased risk of PE due to the pathophysiological
mechanisms described is of considerable clinical interest. The only advice I
suggest to the authors is to add a comment on the fact that the data from this
study give a further reason to push pregnant women to get vaccinated given
the dangers associated with even asymptomatic forms of COVID19.

Author Response

We thank the Reviewer for his/her consideration and appreciation of our communication. 

We also thank the Reviewer for the suggestion; we added the comment about the importance of vaccination in pregnancy.

Back to TopTop